Safety and Efficacy Results from CLI120-001 a Phase 1 Study in RR-AML and HR-MDS: Update from Higher Dose LevelsEwa Lech‐Marańda, Jan Maciej Zaucha, Natalia Jakacka et al.|Blood|2023Cited by 1